Earnings Reports(In thousands, except per-share amounts)

Company Symbol/ Revenues / Profits Pershare R & D Cash Shares Period % change Current/comp Current/comp % Change or Equiv.Advanced Polymer APOS/2Q 4,376/-14% (2,732)/(2,788) (0.18)/(0.21) 1,876/-14% 7,762 14,867Athena Neuroscience ATHN/2Q 7,801/76% (5,569)/(4,328) (0.27)/(0.25) 6,203/28% 47,925 20,825Belmac BLM/2Q 6,774/49% (1,067)/(1,473) (0.05)/(0.10) NA/NA NA 22,260Cortech CRTQ/2Q 656/-58% (6,502)/(2,639) (0.37)/(0.18) 6,071/76% 49,516 17,494ESCAgenetics ESN/1Q 322/50% (1,824)/(1,603) (0.26)/(0.32) 1,635/21% NA 6,980Ecogen EECN/2Q 8,820/68% (1,282)/(3,990) (0.07)/(0.23) NA/NA 8,928 17,822Epitope EPT/3Q 1,359/37% (3,801)/(3,329) (0.36)/(0.38) NA/NA 18,330 10,645HemaCare HEMA/2Q 2,873/2% (516)/(763) (0.10)/(0.17) 670/8% NA 4,995InnoVet IVT/2Q 2,748/-1% (705)/(1,017) (0.04)/(0.06) NA/NA NA NAInSite Vision INSV/2Q 315/160% (3,718)/(1,960) (0.41)/(0.62) 2,210/70% 24,707 8,972ICN Biomedicals BIM/2Q 15,171/-2% 536/3,384 0.06/0.15 NA/NA NA 9,061IMRE IMRE/2Q 1,462/-18% (1,623)/(951) (0.11)/(0.06) NANA NA 15,088MGI Pharma MOGN/2Q 3,269/251% (937)/(2,623) (0.08)/(0.23) 1,361/-18% 19,847 11,692Mycogen MYCO/2Q 34,560/-19% 6,021/2,843 0.30/0.14 4,029/-30% 35,326 19,066N. Amer. Biologicals NBIO/2Q 41,644/84% 2,093/749 0.12/0.06 NA/NA NA 17,077Neurex NXCO/3Q 783/86% (2,906)/(1,582) (0.28)/(1.37) 1,999/45% 13,293 10,322Neurogen NRGN/2Q 1,247/-7% (1,588)/(926) (0.18)/(0.10) NA/NA 8,672 8,974Oncor ONCR/2Q 2,675/28% (5,819)/(2,845) (0.27)/(0.17) 2,186/3% NA 19,550Osteotech OSTE/2Q 5,713/33% 128/101 0.02/0.01 783/6% NA 7,904Quadra Logic1 QLTIF/2Q 912/313% (3,365)/(2,820) (0.17)/(0.18) NA/NA 40,102 19,670Somatix SOMA/4Q 900/100%2 (3,719)/(3,865) (0.24)/(0.29) 3,859/26% 20,222 14,417SPI Pharmaceuticals SPI/2Q 78,927/19% 5,245/1,091 0.25/0.05 NA/NA NA NATeva TEVIY/2Q 125,048/-15% 13,920/18,151 0.26/0.333 10,607/-32% NA 54,845Xenova4 XNVAZ/2Q 854/-47% (3,098)/(1,164) (0.36)/(0.14) 3,456/34% 22,396 8,701

All symbols are NASDAQ except Belmac, ESCAgenetics,Epitope, ICN Biomedicals, InnoVet and SPIPharmaceuticals, all of which are AMEX.1Quadra Logic's figures are in Canadian dollars.2Somatix Therapy reported no revenues in comparable1993 quarter.3Teva's per-share figures reflect ARDs, which represent 10ordinary shares.4Xenova figures have been converted into U.S. dollars.

(c) 1997 American Health Consultants. All rights reserved.